Company / Capital Expenditures
RHYTHM PHARMACEUTICALS, INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$953.0K
FY2025
5-year range
$0 / $953.0K
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#115 of 194
Health Care
What the data says
At $953,000, RHYTHM PHARMACEUTICALS, INC.'s capital expenditures ranks #115 of 194 in the Health Care sector. Capital Expenditures returned to growth in FY2025 after 3 years of decline, reaching $953,000.
Based on SEC 10-K filings.
$953,000 in FY2025 with a 5-year CAGR of +34.8%.
Improved from $47,000 to $953,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +50.2%
- 5-Year CAGR
- +34.8%
- 10-Year CAGR
- -
Sector benchmark
#115 of 194 in Health CareTop 59% of 194This company $953.0K Sector average $117.5M
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +34.8%, indicating consistent growth.
- Ranks #115 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2019.
- Lowest capital expenditures in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $953.0K | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $47.0K | -83.3% |
| FY2022 | $281.0K | -35.3% |
| FY2021 | $434.0K | +102.8% |
| FY2020 | $214.0K | -93.7% |
| FY2019 | $3.4M | +368.8% |
| FY2018 | $722.0K | +442.9% |
| FY2017 | $133.0K | -87.4% |
| FY2016 | $1.1M | +6117.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026